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Abstract
MicroRNAs (miRNAs) are small, non-coding RNAmolecules that regulate gene expression
post-transcriptionally. MiRNAs are implicated in various biological processes associated
with obesity, including adipocyte differentiation and lipid metabolism. We used a neuronal-
specific inhibition of miRNA maturation in adult mice to study the consequences of miRNA
loss on obesity development. Camk2a-CreERT2 (Cre+) and floxed Dicer (Dicerlox/lox) mice
were crossed to generate tamoxifen-inducible conditional Dicer knockouts (cKO). Vehicle-
and/or tamoxifen-injected Cre+;Dicerlox/lox and Cre+;Dicer+/+ served as controls. Four co-
horts were used to a) measure body composition, b) follow food intake and body weight dy-
namics, c) evaluate basal metabolism and effects of food deprivation, and d) assess the
brain transcriptome consequences of miRNA loss. cKO mice developed severe obesity and
gained 18 g extra weight over the 5 weeks following tamoxifen injection, mainly due to in-
creased fat mass. This phenotype was highly reproducible and observed in all 38 cKOmice
recorded and in none of the controls, excluding possible effects of tamoxifen or the non-in-
duced transgene. Development of obesity was concomitant with hyperphagia, increased
food efficiency, and decreased activity. Surprisingly, after reaching maximum body weight,
obese cKOmice spontaneously started losing weight as rapidly as it was gained. Weight
loss was accompanied by lowered O2-consumption and respiratory-exchange ratio. Brain
transcriptome analyses in obese mice identified several obesity-related pathways (e.g. lep-
tin, somatostatin, and nemo-like kinase signaling), as well as genes involved in feeding and
appetite (e.g. Pmch, Neurotensin) and in metabolism (e.g. Bmp4, Bmp7, Ptger1, Cox7a1).
A gene cluster with anti-correlated expression in the cerebral cortex of post-obese com-
pared to obese mice was enriched for synaptic plasticity pathways. While other studies
have identified a role for miRNAs in obesity, we here present a unique model that allows for
the study of processes involved in reversing obesity. Moreover, our study identified the cor-
tex as a brain area important for body weight homeostasis.
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Introduction
MicroRNAs (miRNAs) are small, non-coding RNA molecules that act as post-transcriptional
repressors of gene expression. They promote mRNA decay and inhibit translation by base
pairing to the 30 untranslated regions of target transcripts. In mammals, they may target as
much as 50% of all protein-coding mRNAs [1]. MiRNAs are involved in most cellular process-
es investigated thus far [2] and their dysregulation contributes to many human diseases [3,4].
Functional studies implicate miRNAs in the regulation of metabolism and in metabolic disor-
ders related to cholesterol and lipid metabolism, adipocyte differentiation, insulin secretion,
and glucose homeostasis [5,6]. MiRNAs therefore gain growing attention in the field of diabe-
tes and obesity research.
In vertebrates, the generation of mature miRNAs critically depends on the RNase-III en-
zyme DICER [7]. In the central nervous system, the cell type-specific deletion of Dicer has re-
vealed essential roles for miRNAs in neural differentiation and proliferation, as well as in brain
development and cognitive function [8–11]. To circumvent the neurodevelopmental problems
associated with Dicer deficiency [12], we used an inducible, neuron-specific conditional knock-
out system based on Camk2a-driven CreERT2, to delete Dicer in adult mice using tamoxifen
[13]. This strategy has previously been shown to cause a down-regulation of miRNAs in
Camk2a-expressing cells [10]. We observed that the neuron-specific deletion of Dicer rapidly
induced severe and highly reproducible obesity. Importantly, the obesity phenotype was tran-
sient and spontaneously reversed to join the normal growth curve of untreated littermate con-
trols. The development of obesity was associated with transcriptional changes in the cerebral
cortex, affecting several obesity-related pathways and the control of feeding behavior.
Methods
Animals and housing conditions
All mice used in this study were individually housed in polycarbonate cages (31 × 18 × 18 cm)
in a sound-attenuated and temperature/humidity-controlled room (25°C, 50–60% respective-
ly). Mice were kept under a 12h light/ 12h dark cycle (lights on at 9 am, 70–90 lux) and had ac-
cess to food and water ad libitum. Camk2a-CreERT2 and Dicerlox/lox mice were purchased from
Jackson laboratory (Bar Habor, ME, USA; Stock Number 012362 and 006366, respectively). All
experiments were approved by the Ethical Committee of the State of Vaud Veterinary Office,
Switzerland.
Generation of Dicer conditional knockout (cKO) mice
Dicer cKO (Cre+/Dicerlox/lox) were obtained by crossing hemizygous Camk2a-CreERT2 (Cre+)
animals with homozygous Dicer floxed (Dicerlox/lox) mice. Both lines were created on a mixed
129/SvxC57BL/6 and maintained on a C57BL/6J background by backcrossing to C57BL/6J ani-
mals for at least 9 generations. The Camk2a-CreERT2 transgenic mouse line expresses a ta-
moxifen-activable Cre-recombinase under the control of the brain-specific Camk2a (calcium/
calmodulin-dependent protein kinase II alpha) promoter [14]. The Dicer conditional allele
contains loxP sites on either side of exon 24 of the Dicer1 gene, an exon encoding most of the
second RNase III domain. Cre-mediated recombination results in the removal of 90 amino-
acids of the protein [15]. Genetic recombination was induced in adult mice by treatment with
the exogenous estrogen-receptor ligand tamoxifen, according to Metzger and Chambon [13].
Tamoxifen was purchased from Sigma-Aldrich, Buchs, Switzerland (Product N°: T-5648) and
dissolved in a sunflower seed oil/ethanol mixture (10:1) at a final concentration of 10mg/ml.
The suspension was sonicated for 10 minutes to obtain a homogeneous solution. 8-week-old
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animals were injected intraperitoneally with 1mg of tamoxifen (100μl) twice a day over five
consecutive days. Each mouse thus received a total of 10mg of tamoxifen. Control animals
were injected with 100μl of sunflower seed oil/ethanol mixture (vehicle) at the same frequency.
In all experiments, vehicle-injected Cre+;Dicerlox/lox animals served as controls. For the meta-
bolic assay, tamoxifen- and vehicle-injected Cre+/Dicer+/+ mice were used as additional con-
trols, to exclude a possible effect of tamoxifen itself, or of the non-induced Cre-transgene.
Genotyping Cre+ and Dicerlox/loxmice
Mouse ear-punch samples were used for genotyping the presence of the Cre transgene and the
floxedDicer alleles (Fig. 1A and B). DNA was extracted and purified using the Maxwell 16 Tissue
DNA Purification Kit (Promega AG, Dübendorf, Switzerland) according to the manufacturer’s
instructions. 2.5 μl of the supernatant was used for Polymerase Chain Reaction (PCR) amplification
with specific primers for the Cre transgene (Forward: 50AGGTGTAGAGAAGGCACTTAGC30
and Reverse: 50CTAATCGCCATCTTCCAGCAGG30) and a positive control (Forward:
50CCAATCCCTTGGTTCATGGTTGC30 andReverse: 50CGTAAGGCCCAAGGAAGTCCTGC30)
and the Dicer floxed and deleted allele (Forward: 50CCTGACAGTGACGGTCCAAAG30, Re-
verse: 50CATGACTCTTCAACTCAAACT30, Deleted: 50GGGCAGCCCCATCTCAAAGGCC
TACCTGAG30). PCR products were loaded on 2% agarose gels to check the presence of the
Cre transgene (450 bp), and its positive control (230 bp), the wild type Dicer allele (351 bp), the
Dicer floxed allele (420 bp), and the deleted allele (571 bp; Fig. 1).
Verification of the recombination by RT-PCR
cDNA was synthesized from 1μg of total RNA from the hippocampus of cKO and control mice,
using random hexamers and SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA)
according to manufacturer’s instructions. cDNA was PCR-amplified using FastStart Universal
SYBR Green Master mix (Roche, Basel, Switzerland). To quantify the appearance of exon23-25
spliced transcript upon knockout of exon 24, we used two different pairs of primers targeting
the junction between exon 23 and 25: E23/25−2 (Forward: 50ACGCCTCCTACCACTA
CAAC30 and Reverse: 50TTTCTCCTCATCCTCCTCGG30) and E23/25@3 (Forward:
50AACACTATCACTGCTTAGGAGAT30 and Reverse: 50TGGGGACTTCGATATCCTCTTC30).
Expression of the skipped exon 23–25 was normalized to that of exon 21, taken as an internal
reference (Forward: 50GAGTCACCTGCTAAGCTCCA30 and Reverse: 50ACATT
CATTGCTGGGCTTGG30). Exon 21 expression was quantified to assess the overall down-
regulation ofDicermRNA, and normalized to three reference genes: Eef1a1 (Forward: 50
TCCACTTGGTCGCTTTGCT30 and Reverse: 50CTTCTTGTCCACAGCTTTGATGA30),
Nudt4 (Forward: 50 AAGTTCAAGCCCAACCAGACG30 and Reverse: 50TCCTGGGACA
ATCCATTGGTC30), and Trip12 (Forward: 50 TCCCTGGGATCTACAACACCA30 and Re-
verse: 50ATCATCTCTGCTATGCTGCAAG30). The mean expression level for each exon in cKO
samples was expressed relative to that of the control samples (n = 2/genotype).
Body weight and composition
Three cKO and 3 control mice were used to assess body weight changes over 90 days, starting
the day of the first injection (day 0). Fat and lean body mass were determined on isoflurane-
anesthetized animals using a whole-body composition analyzer (EchoMRI LLC, Houston, TX,
USA) on day 65.
Neuronal Dicer Deletion Leads to Reversible Obesity in Mice
PLOS ONE | DOI:10.1371/journal.pone.0116760 January 28, 2015 3 / 18
Food intake
Four cKO and 4 control mice were used to follow food intake and body weight dynamics. Start-
ing at the day of tamoxifen/vehicle injection, body weight and food consumption were measured
every 2–3 days over 17 weeks. Food efficiency was calculated on a weekly basis, as follows:
Food efficiency½t ¼ ððbody weight½t  body weight½t1Þ=ðfood intake½t  food intake½t1ÞÞ  100
where [t] and [t−1] indicate consecutive weeks.
Figure 1. Verification of the genetic recombination inDicer conditional knockout (cKO) mice. A. PCR of genomic DNA to test for the presence (left
lane;Cre+; 450 bp PCR product) orabsence (right lane;Cre−; 230 bp control band) of theCre transgene.B and C. PCR of Dicermice to test the presence of
loxP sites surrounding exon 24 of Dicer. The wild type allele resulted in a 351 bp band, whereas the presence of loxP sites resulted in a 420 bp PCR product,
as expected.C and D. InjectingCre+;Dicerlox/loxmice with tamoxifen led to the Cre-mediated excision of exon 24. PCRs were carried out on three different
brain tissues i.e., cortex (Cx) hippocampus (Hi), hypothalamus (H), with three primers (i.e. Forward (Fwd) and Reverse (Rev) and Forward and Deleted (Del),
see C. Only the brain samples from tamoxifen-induced Dicerlox/loxmice showed the 571 bp band that is diagnostic of productive recombination at the Dicer
locus (red box in left panel of D). The large band of 1300 bp in the unfloxed mice (Dicer+/+) originated from primers Forward and Deleted on the wild-type
allele. Note that recombination occurred only in the brain and not in liver (L). Also note that the Dicerlox/loxmice injected with tamoxifen still showed the non-
recombined band (420 bp), indicating that not all cells in the tissue recombined, as expected from the presence of Camk2a-negative neurons and non-
neuronal cells. E. Tamoxifen injection in Cre+;Dicerlox/loxmice (n = 2/genotype) resulted in a down-regulation of DicermRNA in the hippocampus, indicated
by the decrease in exon 21 expression, and in an increase in the splicing of exon 23 onto exon 25. Expression of the exon23–25 splice variant was quantified
using two different primer pairs; i.e., E23/25−2 and -3. Exon 21 expression was normalized to that of 3 reference genes, the expression of the exon23-25
splice variant to that of exon 21. Control values were set to 1.
doi:10.1371/journal.pone.0116760.g001
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Metabolism
Four experimental groups were used to analyze metabolic parameters: cKO mice (n = 6),
control mice (n = 6), and Cre+/Dicer+/+ injected with tamoxifen or vehicle (n = 6 and 5, respec-
tively). Indirect calorimetry was performed using the Oxymax system (Columbus Instruments,
Columbus, OH, USA). Metabolic rate was analyzed over the course of a ‘fed-fasted-refed’ pro-
tocol, in which mice were fed ad lib for 72h (i.e., 3 consecutive 24h days starting 2.5h before
dark onset). On day 3, food was removed 2.5h before dark onset for 15h, and for the subse-
quent 24h mice were refed ad lib. Oxygen consumption (VO2) and carbon dioxide production
(VCO2) were measured to calculate energy expenditure (heat production) and the respiratory
exchange ratio (RER). Due to a technical problem of the calorimeter, food intake could not be
reliably measured during the metabolic experiments. Mice were recorded twice; 21 and 42 days
after tamoxifen/vehicle treatment with the first recording occurring at the beginning of the
weight gain phase and the second recording immediately after body weight peaked; i.e., at the
beginning of the decreasing phase.
Statistical analysis
cKO and control groups were compared using unpaired, 2-tailed Student’s t-tests. Time
courses were analyzed by 2-way repeated measures (RM) ANOVA with factors ‘Time’ and
‘Treatment’; LSD tests were used as post-hoc analysis. Significance threshold was set at p =
0.05.
Gene expression
Twelve cKO and 12 control mice were used for analyses of gene expression in different brain
regions. Transcriptome analyses were performed at two time points; 4 weeks after tamoxifen/
vehicle treatment, when mice were already obese but did not reach their peak body weight, and
8 weeks after treatment when the mice were losing weight and returning to normal body
weight. Animals were sacrificed 3–4 h after light onset and cerebral cortex, hypothalamus, and
hippocampus were dissected using a microscope as follows: the hypothalamus was extracted
from the ventral side of the brain, as described in [16]; resulting in a sample measuring 2mm
from either side of the third ventricle laterally, from optic chiasm to the posterior border of the
mammillary bodies, and the thalamus dorsally. For cortex and hippocampus dissection, two
2mm-thick sagittal slices taken 1mm lateral from the inter-hemispheric fissure were cut using
a sagittal slicer matrix (Alto Stainless Matrices, Stoelting CO, IL, USA) in PBS (Life Technolo-
gies Europe, Zug, Switzerland). From the two resulting slices, hippocampi and cortex were dis-
sected according to the Mouse Brain Atlas [17]. Brain tissues were homogenized in QIAzol
Lysis Reagent (Qiagen, Hombrechtikon, Switzerland). Total RNA was extracted and purified
using the RNeasy Lipid Tissue Mini Kit 50 (Qiagen, Hombrechtikon, Switzerland) according
to manufacturer’s instructions. All RNA sample amounts were measured with a NanoDrop
ND-1000 spectrophotometer (Thermo Scientific, Wilmington, NC, USA) and the quality of
RNA samples was verified on Agilent 2100 bioanalyzer chips (Agilent technologies, Basel, Swit-
zerland). Total RNA (100ng) was used to perform target preparation using Ambion WT Ex-
pression Kit (Life Technologies Europe, Zug, Switzerland). 5.5μg of each fragmented cDNA
was end-labeled with biotin and hybridized to a Mouse 430.2.0 Microarray (Affymetrix, Santa
Clara, CA, USA) according to manufacturer’s instructions. For each brain region, tissues from
3 animals per treatment and time point were used, resulting in a total of 12 arrays/tissue (36 ar-
rays total). Microarrays were processed and scanned according to standard procedures. Expres-
sion data were normalized and summarized with the robust multi-average (RMA) method
implemented in the Affymetrix Expression Console. In addition, the MAS5 normalization
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algorithm was run to obtain a detection call for each probe set on each array. These algorithms
were applied separately to the data from each tissue. Probe sets not called present in at least
3 samples and unannotated probe sets (Affymetrix annotation na33) were removed resulting
in 140713 probe sets in cortex, 140527 in hippocampus, and 150460 in hypothalamus. For each
gene we kept the probe set with the highest variance across the 12 arrays from a tissue. Limma
was used to fit a linear model to the expression data with the four conditions as factors [18].
The comparisons between tamoxifen and vehicle treated animals at each time point were ex-
tracted using contrast matrices. P values were adjusted for multiple testing with Benjamini and
Hochberg’s method to control the false discovery rate (FDR) [19]. Since the expression of
many genes in the cortex was altered at 4 weeks with a low fold-change, we applied a non-strin-
gent FDR cut-off of 15%. GeneGo Software (MetaCore, Thomson Reuters, New York, NY,
USA) was used for biological analysis of the enriched pathways and cellular processes between
cKO and control animals in the microarray data. Raw data are available on GEO database
(Accession Number GSE61937).
Results
Tamoxifen injection induces a brain-specific deletion of Dicer exon 24
Tamoxifen injection in adult mice induced the proper excision of Dicer exon 24 in Cre+;
Dicerlox/lox mice (cKO mice) but not in Cre+;Dicer+/+ control mice (Fig. 1). Recombination in
cKO occurred only in the three brain regions tested; i.e., cortex, hippocampus, and hypothala-
mus, but not in the liver, and only brain samples from tamoxifen-injected Dicerlox/lox mice
showed the 571 bp band that is diagnostic of the recombination at the Dicer locus (red box in
left panel of D). Vehicle-injected Cre+;Dicerlox/lox and tamoxifen-injected Cre+;Dicer+/+ did not
show any recombination, in none of the tissues tested (Fig. 1D). The large band of 1300 bp in
the unfloxed mice (Dicer+/+) originated from primers Forward and Deleted on the wild-type al-
lele. However, cKO mice still showed the non-recombined band (420 bp), indicating that not
in all cells recombination occurred, as expected from the presence of non-Camk2a-expressing
neurons and other cells (e.g. glia). We reasoned that in the absence of exon 24, there would be
an increased splicing of exon 23 onto exon 25, which could serve as an independent and quan-
tifiable molecular marker for knockout efficiency. Indeed, in the hippocampus of cKO animals,
we found a significant increase in exon23-25 splicing (Fig. 1E). Moreover, the level of Dicer
mRNA seemed down-regulated in the hippocampus of cKO mice, as exemplified by the reduc-
tion in exon 21 (Fig. 1E), consistent with the results reported by Konopka et al. [10].
The neuronal knock-down of Dicer induces severe but transient obesity,
associated with hyperphagia and altered food efficiency
The brain-specific deletion of Dicer led to the rapid development of obesity, in all cKO animals
we tested thus far (n = 38 in total). In a first cohort, cKO mice accumulated 18.5 g extra weight
(or +59%), 47.5 days after tamoxifen injection compared to controls (Fig. 2A and 2B). This in-
crease in body weight was mainly due to an increase in fat mass (Fig. 2B). The time at which
body weight peaked did, however, differ among the experimental groups in which the exact
peak time was determined [experiment 1 (body composition): day 47.5±1.5, n = 3; experiment
2 (food efficiency): day 38.5±0.5, n = 4; experiment 3 (indirect calorimetry): day 42.0 ±0.0, n =
6; ANOVA factor ‘cohort’: p<0.01; all 3 experiments: day 42.2±0.9, n = 13]. Weight gain at
peak time did not significantly differ among cohorts (+12.4±2.2 g or +39%, n = 13 cKO vs.
26 controls). The increase in body weight was associated with increased food intake and food
efficiency (Fig. 2C and S1 Fig.), suggesting that obesity was not solely due to increased food
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intake, but that both hyperphagia and reduced metabolism contributed to the rapid accumula-
tion of white adipose tissue.
After reaching maximum body weight, cKO mice spontaneously entered a fast descending
phase in which they lost weight as rapidly as it was gained (Fig. 2C). The switch from gain to
loss occurred within a very short time window and was highly reproducible in that in each of
the 38 cKO mouse from 4 independent experimental cohorts showed the same pattern of body
weight changes after recombination. At the switch from weight gain to weight loss, cKO mice
entered a catabolic state in which food intake abruptly changed from strong hyperphagia to
mild hypophagia documented in Fig. 2C by the steep positive slope in cumulative feeding be-
tween days 18–39 (i.e., the linear phase of increase: +1.6 gr/day, R2 = 0.99, P<0.001) to the
Figure 2. Dicer cKOmice show transient obesity. A. Photographs of two representative Cre+;Dicerlox/loxmice injected either with tamoxifen (cKO, 55.2 gr)
or vehicle (27.2 gr) taken 49 days after injection. The same two mice are represented from a dorsal (left picture) and frontal (right picture) view.B. Upper
panel. Body weight of cKO and control mice at day 49 (n = 3/group). Lower panel. Fat and lean body mass of cKO and control mice at day 65 (n = 3/group).
Note that at this time, body weight in cKOmice already decreased. C. Body weight and food intake in cKOmice and controls (n = 4/group) over a 17-week
period. Dashed grey panel highlights the 5 days of tamoxifen treatment. cKOmice increased their body weight concomitant with increasing food intake until
reaching a maximum at day 38. Values reverted to control levels within 3 weeks. Food efficiency was calculated per week. Data expressed asmean (±1 SEM).
cKO and control mice are represented in blue and black, respectively. Stars mark significant differences (t-tests p<0.05).
doi:10.1371/journal.pone.0116760.g002
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slight but significant negative slope between days 39–70 (−0.1 gr/day, R2 = 0.62, P<0.001;
linear regression on mean values). This mild hypophagia is, however, not sufficient to explain
the pronounced and fast decrease in body weight. This discrepancy is compellingly illustrated
by the large negative food efficiency values observed during the catabolic state that dropped
from +9.1 during obesity to −5.2%, while in control mice food efficiency remained constant at
an intermediate +2.6% throughout the experiment (Fig. 2C). Finally and similarly surprising
was the observation that after losing the extra weight they gained, cKO mice joined the normal
growth curve of the control mice (Fig. 2C). These data strongly suggest that both altered feed-
ing and disturbed metabolism contributed to this unique obesity phenotype.
Obesity is associated with reduced basal metabolism, reduced
locomotor activity, and unresponsiveness to fasting
To further investigate this metabolic aspect, indirect calorimetry was used to assess oxygen
consumption (VO2), heat production, and locomotion at two time points. A first, 5-day
recording was carried out starting 21 days after tamoxifen injection; i.e., the time food efficien-
cy started increasing in cKO mice just before entering the ascending phase of body weight gain
(referred to as “pre-obese”). This 5-day experiment was repeated on day 42 after tamoxifen in-
jection; the time window when mice reached peak body weight (referred to as “obese”). cKO
mice were compared to three control groups: Cre+;Dicer+/+ mice injected with tamoxifen and
Cre+;Dicer+/+ and Cre+;Dicerlox/lox mice injected with vehicle. No difference was observed
among the three control groups (p>0.1, see S2 Fig.) and values were averaged for presentation.
The lack of a difference among controls demonstrated that the effects observed were not due to
tamoxifen or to the Cre-transgene.
During baseline, pre-obese cKO mice had normal respiratory exchange ratio (RER) and
VO2 values, but were less active (Fig. 3; ANOVA, factors ‘Time’ and ‘Group’: p<0.001). Obese
cKO mice showed a lower baseline metabolism, as evidenced by a lower VO2 (Fig. 3A and B)
and a lower RER (preferential lipid oxidation), consistent with a catabolic state. In addition,
obese cKO mice, like the pre-obese cKO mice, were less active than control mice (Fig. 3D).
To evaluate metabolic adaptation to changes in energy supply, mice were challenged with a
15h period of fasting. In control animals, fasting induced a decrease in metabolism (i.e., re-
duced VO2 and heat production, Fig. 3B and 3C), a metabolic switch to lipids (decrease in
RER; Fig. 3A), and increased locomotor activity, likely reflecting food seeking behavior
[Fig. 3D [20]]. In pre-obese cKO mice, fasting induced a larger drop in both VO2 and heat pro-
duction as compared to controls (Fig. 3B and C). Conversely, in obese cKO mice, fasting only
marginally reduced VO2 and heat production compared to controls (Fig. 3B and C) likely as a
result of the baseline state being already catabolic, consistent with the lower RER in both fed
and refed states. Interestingly, cKO mice were also less responsive to fasting in terms of en-
hancing locomotor activity (Fig. 3C and D). This lack of food-seeking behavior did not depend
on body weight and was observed in both the pre-obese and obese states (analysis not shown).
Together, these data indicate that neuronal deletion of Dicer disrupted metabolic balance and
impaired behavioral and metabolic adaptation to rapid changes in energy supply.
The brain transcriptome of obesity dynamics
Although conditional Dicer deletion has been shown to importantly decrease most miRNAs in
the targeted cells [10,12,21,22], to gain insight into the specific molecular pathways that could
underlie the obesity phenotype, we investigated the changes in mRNA expression in the brain.
We performed cortical, hypothalamic, and hippocampal transcriptome analyses, in a fourth
cohort 4 weeks after treatment, when mice showed body weight gain (+8.1±1.1 g or +28.3%,
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n = 6 compared to controls; t-test p<0.001), and 8 weeks after treatment, when body weight no
longer differed from control levels (+4.8±2.4 g or +14.9%; t-test p = 0.11). At 4 weeks, we ob-
served a large number of transcripts that were significantly affected by the absence of Dicer
specifically in the cerebral cortex (Fig. 4 and S3 Fig.). For both the 4- and 8-week time points,
no differences could be observed in the hypothalamus, neither in the hippocampus (S3 Fig.).
This lack of response was not due to a larger variability among biological replicates in these
two tissues compared to cortex (S4 Fig.).
In the cortex, 1020 genes were differentially expressed in cKO mice 4 weeks after treatment.
Of those, 828 (i.e., 81%) were up-regulated (Fig. 4A, S1 Table). Several among those have docu-
mented links to feeding control and maintaining proper energy balance; e.g., the leptin receptor
(Lpr) and pro-melanin-concentrating hormone (Pmch) were up-regulated, as were neurotensin
(Nts) and its receptor (Ntsr1; Fig. 4A and C, S1 Table). Expression of other genes, such as
Nemo-like kinase (Nlk) and somatostatin receptor 3 (Sstr3) were down-regulated in cKO mice
and thus are unlikely direct miRNA targets. Interestingly genes involved in heat production
through white-to-brown adipocyte transition, such as prostaglandine E receptor 1 (Ptger1),
cytochrome c oxidase (Cox7a1) and bone morphogenetic proteins (Bmp4-7) were also found
up-regulated in the cortex of cKO mice (Fig. 4C, S1 Table). Other genes that participate in lipid
metabolism (Dgkd, Far1, Pld1, Stard4) and immune-related responses (Hsp90aa1, Hspb8, Il22,
Il4) showed significantly changed expression as well (Fig. 4C, S1 Table). Among the top 10
gene-ontology pathways for this group of 1020 affected transcripts, we found an enrichment
for several immune response and inflammation-related pathways (Fig. 5A).
At 8 weeks, no genes were found differentially expressed in the cortex of cKO and control
mice. Nevertheless, a specific cluster of genes showed an anti-correlated effect between the two
time points (Fig. 4B, S2 Table) and which therefore might be involved in restoring metabolic
balance. Pathway and cellular processes enrichment analysis on the 1094 genes belonging to
this cluster showed that enriched pathways were linked to synaptic plasticity and AMPA
receptors in particular, whereas enriched cellular processes were mostly associated with cell
morphogenesis and cellular component organization (Fig. 5B).
Discussion
Here, we described the use of a transgenic approach to investigate the consequences of adult
neuronal miRNA loss on body weight, feeding behavior, and metabolism in adult mice. The
time- and brain-specific deletion of Dicer in adult mice occurred only in a sub-population of
cells, mostly post-mitotic neurons of hippocampal and cortical origin. Although Camk2a-ex-
pressing neurons are abundantly present in these two areas [10,14], Camk2a-negative neurons
and non-neuronal cells are thus expected to contribute to the presence of non-recombined al-
leles. Future experiments using different approaches (e.g. FACS sorting neurons based on
Camk2a-expression and/or determining the cell-type specificity of the recombination by in
situ hybridization for Dicer and/or for specific miRNAs) could help to define the precise molec-
ular mechanisms underpinning the phenotype. In the recombined cells, the excision of exon
24 resulted in lower levels of DicermRNA, consistent with previous reports [10, 21]. This
Figure 3. Dicer cKOmice show reduced basal metabolism and activity, and an altered response to fasting.Metabolic parameters and locomotor
activity were measured during an ad lib fed state (72h baseline) followed by a 15h overnight fasting period and subsequent 24h refeeding. Data are shown as
mean (±1 SEM) and statistical differences are indicated by stars above graphs (t-tests, p<0.05). Values of the three control groups (see text) were averaged.
A and B. Compared to control mice (black; n = 18), obese cKOmice (blue; n = 6) showed reduced respiratory exchange ratio both under baseline and in
response to fasting, mostly due to a lower VO2. Pre-obese mice show only a reduction in VO2 during fasting. C. Both pre-obese and obese cKOmice fail to
enhance locomotor activity and showed a larger and smaller drop in heat production, respectively.D. Obese cKOmice have an overall reduction of locomotor
activity, both in baseline and in response to fasting.
doi:10.1371/journal.pone.0116760.g003
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decrease in DicermRNA is probably due to a lower stability of the mutant transcript because
pre-mRNA levels were not altered [21].
The neuronal-deletion of the miRNA-processing enzyme DICER led to the development of
rapid and transient obesity in mice. Surprisingly, this phenotype has not been described by oth-
ers using a very similar Dicer cKO strategy in adult mice, neither in mice lacking Dicer in neu-
rons from birth (i.e., non-inducible Camk2a-Cre+; Dicerlox/lox mice) [10,23]; but see statement
below). In the latter model, whole brain transcriptome analysis showed an up-regulation of
transcripts involved in regulating gene expression through chromatin modifications, whereas
down-regulated genes were associated with neuronal function and axogenesis [23]. The same
study found that although many miRNAs were affected, no particular enrichment was found
for their targets among the genes for which mRNA levels changes were found [23], illustrating
the difficulty of identifying specific molecules using genome-wide approaches.
Figure 4. Gene expression ofDicer cKO and control mice in the cortex. A. P-value histograms for [cKO-control] comparisons in the cortex at 4 and 8
weeks. The horizontal line represents the number of P values expected by chance. The continuous decrease in P values from 0 to 0.4 suggests that a
majority of genes are differentially expressed at 4 weeks. At 8 weeks none of the transcripts were differentially expressed.B. Scatter plot and distributions of
the moderated t-statistic at 4 weeks and 8 weeks for 140713 genes in the cortex. X- and Y-axis: moderated t from the cKO-control contrast at 4 and 8 weeks,
respectively. At 4 weeks, the t-statistic distribution is skewed with a majority of genes having positive values. At 8 weeks, the distribution is symmetrical with a
modal value close to zero. The three clusters (brown, green, blue) were defined by fitting a two-component Gaussian mixture model on each of the two
marginal distributions (“mclust” R). Brown: data belonging to component 1 in both distributions. Green: data belonging to component 1 in the 4 weeks
distribution and to component 2 in the 8 weeks distribution. Blue: data belonging to the 4 weeks component 1 which did not separate into two distinct clusters
at 8 weeks. C. Mean (±1 SEM) expression of genes related to food intake, thermogenesis, and lipid metabolism (n = 3/condition). Blue bars represent the
cKOmice and black bars the controls. Bars are grouped by 4-week (4 w, left pair of bars) and 8-week (8 w, right bar pair) values.
doi:10.1371/journal.pone.0116760.g004
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Figure 5. Pathway analysis of significant genes at 4 weeks and of the anti-correlated cluster at 8 weeks. A. Top 10 enriched pathways in cKOmice at
4 weeks. The% genes affected within each pathway are represented. The bar colors indicate categories to which the pathway belongs.B. Top 10 enriched
cellular processes (left) and pathways (right) found in the cluster of anti-correlated genes (i.e., the green cluster in Fig. 4B).
doi:10.1371/journal.pone.0116760.g005
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In Dicer cKO mice, the weight gain phase was associated with hyperphagia, increased food
efficiency and reduced metabolism. To what extent hyperphagia is cause or consequence of
metabolic dysfunction is, however, unclear. The hyperphagia, reduced metabolism, and
increased fat mass of our cKO mice is comparable to other mouse models of obesity such as
leptin- and leptin-receptor-deficient mice [24,25], that develop obesity from early age, and a
maturity-onset mouse obese model in which the melanocortin system was targeted [26]. How-
ever, in none of these models a spontaneous reversal of obesity was observed, which is, to our
knowledge, unique to our Dicer cKO mice.
Several miRNAs have been found to be causally involved in obesity [6]. The specific deletion
of themiR-143/145 cluster protected mice from developing dietary-induced obesity [27].
Similarly, overexpression ofmiR-802 led to the development of obesity-associated insulin resis-
tance [28]. Interestingly, inhibition ofmiR-200a could reverse obesity by increasing the level of
the leptin receptor and insulin receptor 2 in the hypothalamus [29]. Conversely, in the hippo-
campus, leptin was recently shown to decrease the expression of several genes directly targeted
bymiR-132, suggesting that leptin can drive the expression of this particular miRNA [30].
These and other miRNAs could thus be regarded as novel targets in the treatment of obesity
and related metabolic disorders. Whether any of the aforementioned miRNAs was responsible
for the obesity phenotype observed in our cKO mice is difficult to assess as deletion of Dicer af-
fects virtually all miRNAs.
Gene expression analysis revealed that most (i.e., 81%) of the affected genes in the cortex
were up-regulated in cKO mice, consistent with an absence of miRNA’s repressor activity. At 4
weeks, several obesity-related genes and genes involved in the control of feeding behavior were
significantly affected in cKO mice; Lpr and Pmch were up-regulated, as were Nts and its recep-
tor Ntsr1. These genes are known to be crucial for maintaining proper energy balance and Lpr
has been previously shown to be under the control ofmiR-200a [29,31,32]. Moreover, both
Pmch and Nts were recently shown to be part of the motivational and hedonic aspect of feeding
behavior [31,32]. Other genes, such as Nlk, which was recently found as part of potential sus-
ceptibility loci for obesity [33], and Sstr3 [34] were also changed in cKO mice. Besides the con-
trol of food intake, also metabolic pathways were deregulated in the cortex of cKO mice. In
particular, several genes involved in thermogenesis through brown adipose tissue and in the
white-to-brown adipocyte transition were affected (e.g., Cox7a1, Bmp4, Bmp7, Ptger1) [35–37],
as well as a whole set of genes related to lipid metabolism and transport (e.g. Far1, Dgkg,
Stard4). Together, these data support the notion of miRNAs being involved in the control of
adipogenesis, lipid metabolism and adaptive thermogenesis.
The brain transcriptome analysis also revealed an enrichment of transcripts that are part of
inflammatory pathways and immune response at 4 weeks, which could have contributed to the
development of the phenotype. Whether inflammation is a cause or a consequence of obesity
is, however, unclear. Chronic inflammation in the circulation and peripheral metabolic tissues
is one of the hallmarks of obesity [38]. Moreover, recent evidence shows crucial roles for
neuroinflammatory processes in metabolic disorders [39], especially in the hypothalamus in
which inflammatory responses could lead to a dysregulation of feeding [40]. These observations
indicate that, besides the specific transcripts known to be causally linked to feeding behavior (see
above), a variety of pathways indirectly associated with energy metabolism were affected in cKO
mice. The dysregulation of neuronal miRNAs thus had wide-ranging and complex effects on
gene expression which likely contributed to the development of the obesity phenotype.
The most interesting observation in our model mice is probably the spontaneous reversal of
obesity. This surprising phenotype indicates that after deletion of miRNAs, compensatory
mechanisms take place to re-establish neuronal networks and these modifications might un-
derlie the recovery of normal energy homeostasis. Our observations of enrichment in synaptic
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plasticity-related pathways are consistent with the remodeling of synapses and changes in
dendritic morphology that has been reported in a similar construct of Camk2a-specific Dicer
deletion [10].
As an alternative explanation to specific miRNAs and their mRNA targets underlying the
dysregulation and subsequent recalibration of metabolic homeostasis, we could surmise that
neuronal loss and subsequent replacement could underlie our unique obesity phenotype. Two
recent studies have used Dicer knockout strategy to delete POMC-neurons in the hypothala-
mus, and reported the development of obesity in parallel to cell death within the first 6 weeks
of age [41,42]. This metabolic phenotype was associated with changes in transcript levels in the
hypothalamus for genes known to be linked to neurodegeneration supporting the idea that
obesity resulted from the loss of specific cells in the brain. The return to normal body weight
regulation that we observe would require restoration of neuronal function through e.g. neuro-
genesis and/or establishment of new neuronal connections. Although research on adult neuro-
genesis has focused mainly on the hippocampus and the subventricular zone of the lateral
ventricle, recent studies reported the existence of neurogenesis in other brain areas, notably in
the hypothalamus and in the cortex, where it has functional implication in the control of feed-
ing behavior [43]. In the cortex of our cKO mice, as stated earlier, several inflammatory path-
ways and immune response genes were enriched at 4 weeks, and neuro-inflammatory
processes are known to trigger neurogenesis [44,45]. Moreover, the time course of weight gain
and loss in the cKO mice fits the time course of adult neurogenesis in rodents, taking place
within 4–7 weeks [46]. Further investigation of cell death and adult neurogenesis in Dicer cKO
mice might help to test this hypothesis.
Contrary to expectation, no differences in gene expression were observed between tamoxi-
fen and vehicle treated Dicer cKO mice in the hypothalamus, a brain region well known for its
role in the control of food intake and energy homeostasis [47], nor in the hippocampus, a re-
gion for which there is growing evidence for an involvement in metabolic control [48]. One
factor that could have contributed to the negative results in the hypothalamus is this tissue’s
higher heterogeneity and transcriptome analyses targeting specific nuclei could be informative.
The fact that many transcripts were affected in Dicer knockout mice were observed in the cor-
tex suggest a role for cortical areas in feeding behavior especially in the motivational aspect of
feeding [48,49].
Conclusion
We have discovered a unique and robust mouse model of obesity in which both the metabolic
dysregulation leading to obesity as well as the homeostatic compensatory processes that correct
this dysregulation can be studied within a short time window. Identifying the processes that
are implicated in the return to normal body weight will bring a new perspective in the treat-
ment of obesity and metabolic disorders.
While this manuscript was under review, Vinnikov et al., similarly reported on transient
obesity in inducible, Camk2a-driven, Dicer KOmice [50]. They confirmed the development of
hyperphagic obesity associated with increased fat mass and a body weight dynamics similar to
that observed in our study, underscoring the robustness and high reproducibility of our results.
Using different techniques, the authors also confirmed that the recombination occurred in sev-
eral brain regions, including the cerebral cortex, hippocampus, and hypothalamus. Obesity in
their mouse model was associated with increased circulating leptin levels, and an increase in
the orexigenic factor NPY in the hypothalamus, an observation that is consistent with our mi-
croarray data suggesting a deregulation of food intake control in the brain. Vinnikov et al,
could identify one miRNA,miR-103, targeting the PI3K/Akt/mToR pathway, as a key
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component of the initial development of obesity. The authors further noted that the deletion of
Dicer induces neurodegeneration in hippocampus specifically, an observation which is in line
with our hypothesis outlined above suggesting that neurodegenerative processes followed by
neurogenesis and associated synaptic plasticity changes and reorganization of cellular networks
could underlie restoration of body weight homeostasis. Together, the two complementary stud-
ies provide mechanistic insight both into the development of body weight gain, as well as into
the reversal of obesity.
Supporting Information
S1 Fig. Food intake accumulation in cKO and control mice. Upper panel. Cumulated food
intake (mean ± 1 SEM) in cKO mice and their controls (n = 4/group) over a 17-week period.
Lower panel. cKO-control differences (mean +/− 1 SEM) in accumulation of food intake. Start-
ing after injection of tamoxifen, cKO mice increased food intake until reaching a maximum at
day 38. Values reverted to control levels within 3 weeks and subsequently followed the normal
growth curve with stable food intake. cKO and control mice are represented by dark and light
blue dots, respectively. Black dots represent the cKO-control differences. Stars above the graphs
correspond to significant results of post-hoc student’s t-tests p<0.05.
(TIF)
S2 Fig. Metabolic parameters in the three control groups and in cKOmice. Data are shown
as mean (± SEM). The three control groups (i.e., Cre+;Dicerlox/lox injected with vehicle, purple
lines and dots, n = 6, Cre+;Dicer+/+ with vehicle, blue lines and dots, n = 5, Cre+;Dicer+/+ with
tamoxifen, green lines and dots, n = 6) and the cKO group (red lines and dots, n = 6) are
shown. No difference was observed between the three control groups, neither at the pre-obese,
nor at obese time point. C. Note that although in all 3 control groups activity increased during
fasting (night 4) there was a significant difference among groups in the degree by which loco-
motor activity was increased (Dark4-Dark3 difference). For details see legend Fig. 3.
(TIF)
S3 Fig. P value histograms for the tamoxifen vs. vehicle comparisons in the three brain re-
gions at 4 and 8 weeks. P values were computed using R package “limma” (see methods). The
horizontal dashed line represents the number of P values expected by chance. For details see
legend Fig. 4.
(TIF)
S4 Fig. Coefficient of variation (CV) within each experimental group. The CV was calculat-
ed as the ratio of the standard deviation divided by the mean of the three biological replicates
for each condition in each tissue. The hippocampus and hypothalamus, that do not show any
difference between tamoxifen and vehicle conditions, do not have a larger within
group variability.
(TIF)
S1 Table. List of transcripts that are significantly changed between cKO and control mice
in the cortex at 4 weeks.
(XLSX)
S2 Table. List of transcripts with anti-correlated expression between 4 and 8 weeks in the
cortex.
(XLS)
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